Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Composition : Mirabegron (E.R.) 25mg
Dosage Form : Tablet
Packaging Type : Alu Alu
Packaging : 10*10
Price : ₹299/-
Miratyle 25 Tablet contains Mirabegron (E.R.) 25mg, a beta-3 adrenergic agonist primarily used to manage symptoms of overactive bladder (OAB). It helps improve bladder control by relaxing the bladder muscles, thereby increasing its capacity to store urine and reducing the frequency and urgency of urination.
This extended-release formulation ensures sustained therapeutic action throughout the day, providing consistent relief from OAB symptoms. Miratyle 25 Tablet is particularly beneficial for individuals experiencing frequent urination, sudden urges to urinate, or episodes of urinary incontinence.
Mirabegron offers an innovative approach to OAB management by targeting beta-3 adrenergic receptors in the bladder. Unlike anticholinergic medications, it has a lower risk of causing dry mouth and constipation, making it a suitable option for long-term treatment. The tablet is designed for easy administration, with once-daily dosing ensuring convenience and compliance.
Common side effects include increased blood pressure, headache, nasopharyngitis, and urinary tract infections. Rarely, dizziness or gastrointestinal discomfort may occur.
For the treatment of overactive bladder (OAB) symptoms, including urgency, frequency, and urge urinary incontinence.
Use only under medical supervision. Inform your doctor if you have high blood pressure, severe kidney or liver impairment, or are pregnant or breastfeeding. Adhere to the prescribed dosage.
Store in a cool, dry place below 30°C, protected from light and moisture. Keep out of reach of children.
Composition : Mirabegron (50mg) + Solifenacin (5mg)
Composition : Mirabegron 50mg + Solifenacine Succinate I.P. 5mg
Composition : Mirabegron (50mg)
Composition : Mirabegron (E.R.) 50mg
Composition : Piracetam (800mg) Tablet
Composition : Piracetam (200mg)
Composition : Levetiracetam (100mg) Injection
Composition : Levetiracetam (1000mg) Infusion
Composition : Levetiracetam (1000mg) Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Strategic Advisory
Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.
View Professional Profile
Start Your Journey
Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!
Quick Navigation